Medtronic, NuVasive, Mazor & more: 9 device company key notes

Here are nine key notes on orthopedic and spine device companies from the past week.

Advertisement

Paris, France-based SpineGuard reported its fiscal year 2016 revenue hit $7.95 million.

 

In the fourth quarter of 2016, Caesarea, Israel-based Mazor Robotics received 21 system purchase orders.

 

Even though Medtronic missed revenue goals in the most recent financial report, an analyst with Seeking Alpha predicts the company will experience “stellar growth” in the next half-decade.

 

The 8th U.S. Circuit Court of Appeals in St. Louis voted unanimously to overturn a ruling from a chief federal judge in Minnesota that threw out a case against Medtronic related to its spinal fusion material Infuse.

 

Bordeaux, France-based Implanet received a new patent for its JAZZ implant’s universal tensioning system.

 

Parsippany, N.J.-based Precision Spine obtained FDA 510(k) clearance for its AccuFit lateral plate system.

 

Toronto, Ontario, Canada-based Titan Medical appointed David J. McNally the new CEO.

 

The Japanese Ministry of Health, Labour and Welfare is allowing San Diego-based NuVasive’s eXtreme Lateral Interbody Fusion procedures to continue in Japan.

 

Atlanta-based Medovex Corp. received SGS’ compliance certification for its DenerveX System.

 

More articles on devices:
Deimos Asset Management buys 15k of K2M shares: 4 quick notes
Medovex receives Switzerland-based certification for DenerveX System: 5 insights
Spine surgery segment leads global spinal intervention products market: 5 key points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.